Bin Li is currently serving as the Plasmid Manufacturing Leader for Global Harmonization and Tech Transfer at Sanofi, a role commenced in 2022. Prior to this, Bin held increasing responsibilities at Sanofi from 2017 to 2022, culminating as Manager of the Pilot Plant within MSAT-Drug Substance. Bin began their career as a Senior Research Associate at Green Biologics, Inc. from 2013 to 2014, followed by a tenure as a Bioengineer/Fermentation Scientist at Eppendorf, Inc. from 2014 to 2017. Bin is also pursuing a Doctor of Philosophy (Ph.D.) in Bioengineering at the University of Toledo.
This person is not in the org chart
This person is not in any teams
This person is not in any offices